Course Description
Course | Code | Semester | T+P (Hour) | Credit | ECTS |
---|---|---|---|---|---|
CLINICS II | - | Spring Semester | 6+0 | 6 | 16 |
Course Program |
Prerequisites Courses | |
Recommended Elective Courses |
Language of Course | Turkish |
Course Level | Second Cycle (Master's Degree) |
Course Type | Elective |
Course Coordinator | Assist.Prof. Büşra Nur ÇATTIK |
Name of Lecturer(s) | Assist.Prof. Neda TANER, Assist.Prof. Rashıda Muhammad UMAR, Assist.Prof. Büşra Nur ÇATTIK |
Assistant(s) | |
Aim | It aims to target teaching advanced level information about cardiovascular system, central nervous system, kidney diseases, skin and soft tissue disorders, pregnancy, lactation and contraception, pain management and local and general anesthetic drugs. |
Course Content | This course contains; Osteoporosis and osteoarthritis and drug used in its treatment ,Acute coronary syndrome and drugs used in its treatment,Dyslipidemia and drugs used in its treatment,Eczema and psoriasis and drugs used in their treatment,Drugs that can be used in Pregnancy and lactation,Contraception methods,Acute kidney failure and drugs used in its treatment,Chronic kidney failure and drugs used in its treatment,Parkinson’s disease and drugs used in its treatment,Epilepsy and drugs used in its treatment,Alzheimer’s disease and drugs used in its treatment,Antidepressant and antimanic drugs,General and local anesthetics,Pain managements. |
Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
1. Analyzes the ability to understand and evaluate drugs used in the treatment of osteoporosis and osteoarthritis. | 11, 12, 2, 3, 4 | A, D, E |
2. Analyzes the ability to understand and evaluate drugs used in the treatment of acute coronary syndrome. | 11, 12, 2, 3, 4 | A, D, E |
3. Analyzes and discusses dyslipidemia and the drugs used in its treatment. | 11, 12, 2, 3, 4 | A, D, E |
4. Analyzes and discusses the drugs used in the treatment of eczema and psoriasis. | 11, 12, 2, 3, 4 | A, D, E |
5. Analyzes and discusses the drugs that can be used during pregnancy and lactation. | 11, 12, 2, 3, 4 | A, D, E |
6. Analyzes and discusses contraception methods. | 11, 12, 2, 3, 4 | A, D, E |
7. Analyzes and discusses acute renal failure and the drugs used in its treatment. | 11, 12, 2, 3, 4 | A, D, E |
8. Analyzes and discusses chronic renal failure and its treatment. | 11, 12, 2, 3, 4 | A, D, E |
9. Analyzes and discusses Parkinson's disease and its treatment. | 11, 12, 2, 3, 4 | A, D, E |
11. Analyzes and discusses the drugs used in the treatment of Alzheimer's. | 11, 12, 2, 3, 4 | A, D, E |
12. Analyzes and discusses antidepressants and antimanics. | 11, 12, 2, 3, 4 | A, D, E |
13. Analyzes and discusses general and local anesthetics. | 11, 12 | A, D, E |
14. Analyzes and discusses pain management. | 11, 12, 2, 3, 4 | A, D, E |
15. Decides on the treatment plan regarding these issues. | 11, 12, 2, 3, 4 | A, D, E |
Teaching Methods: | 11: Demonstration Method, 12: Problem Solving Method, 2: Project Based Learning Model, 3: Problem Baded Learning Model, 4: Inquiry-Based Learning |
Assessment Methods: | A: Traditional Written Exam, D: Oral Exam, E: Homework |
Course Outline
Order | Subjects | Preliminary Work |
---|---|---|
1 | Osteoporosis and osteoarthritis and drug used in its treatment | 1, 2 |
2 | Acute coronary syndrome and drugs used in its treatment | 1, 2 |
3 | Dyslipidemia and drugs used in its treatment | 1, 2 |
4 | Eczema and psoriasis and drugs used in their treatment | 1, 2 |
5 | Drugs that can be used in Pregnancy and lactation | 1, 2 |
6 | Contraception methods | 1, 2 |
7 | Acute kidney failure and drugs used in its treatment | 1, 2 |
8 | Chronic kidney failure and drugs used in its treatment | 1, 2 |
9 | Parkinson’s disease and drugs used in its treatment | 1, 2 |
10 | Epilepsy and drugs used in its treatment | 1, 2 |
11 | Alzheimer’s disease and drugs used in its treatment | 1, 2 |
12 | Antidepressant and antimanic drugs | 1, 2 |
13 | General and local anesthetics | 1, 2 |
14 | Pain managements | 1, 2 |
Resources |
Books: 1. Wells BG (2015) Pharmacotherapy handbook (9th ed), McGraw-Hill 2. Katzung BG (2012) Basic and clinical Pharmacology (12th ed) McGraw-Hill |
Course Contribution to Program Qualifications
Course Contribution to Program Qualifications | |||||||
No | Program Qualification | Contribution Level | |||||
1 | 2 | 3 | 4 | 5 | |||
1 | PY-1. Knows about accessing the scientific information in the field of clinical pharmacy, monitoring, evaluating, and implementing the current literature | X | |||||
2 | PY-2. Has the advanced knowledge of creating patient profiles, patient education, and medication counseling. | X | |||||
3 | PY-3. Cooperates with persons in relevant disciplines at the stages of collecting, interpreting, implementing, and announcing results of data related to the clinical pharmacy field | X | |||||
4 | PY-4. Uses the knowledge and equipment related to administering medicine to patients and the use of the drug. Gives pharmaceutical care service by providing rational and safe drug use with the duty of observance and supervision. | X | |||||
5 | PY-5. Acquires administrative and technical stand-by equipment in the areas where the clinical pharmacy is responsible for and achieves hospital pharmacy practices properly. | X | |||||
6 | PY-6. Produces solutions to the problems in the field of clinical pharmacy in the direction of scientific data/ scientific evidence. | X | |||||
7 | PY-7. Plans, manages, watches the process, and evaluates activities that oriented improvements of employees as part of a project. | X | |||||
8 | PY-8. Carries out a study independently by using advanced level knowledge about the field of clinical pharmacy and takes responsibility as a team member in cooperation with other occupational groups working in this field. | X | |||||
9 | PY-9. Demonstrates embarking on lifelong learning, open for improvement, and continue this behavior. | X | |||||
10 | PY-10. Follows and evaluates national and international developments in the field of clinical pharmacy. | X | |||||
11 | PY-11. Safely documents and keeps track of professional activities and practices. | X | |||||
12 | PY-12. Provides information to the patience, healthcare personnel, and society on every drug-related issue. | X | |||||
13 | PY-13. Informs relevant persons and institutions in the fields of quality assurance of pharmaceutical products | X | |||||
14 | PY-14. Behaves according to the legislation and professional ethics related to duty, right, and responsibilities as an individual. | X | |||||
15 | PY-15. Has sufficient consciousness in the field of individual and public health, environmental protection, and job security and applies it. | X |
Assessment Methods
Contribution Level | Absolute Evaluation | |
Rate of Midterm Exam to Success | 50 | |
Rate of Final Exam to Success | 50 | |
Total | 100 |
ECTS / Workload Table | ||||||
Activities | Number of | Duration(Hour) | Total Workload(Hour) | |||
Course Hours | 14 | 6 | 84 | |||
Guided Problem Solving | 14 | 13 | 182 | |||
Resolution of Homework Problems and Submission as a Report | 14 | 5 | 70 | |||
Term Project | 0 | 0 | 0 | |||
Presentation of Project / Seminar | 0 | 0 | 0 | |||
Quiz | 0 | 0 | 0 | |||
Midterm Exam | 14 | 5 | 70 | |||
General Exam | 14 | 5 | 70 | |||
Performance Task, Maintenance Plan | 0 | 0 | 0 | |||
Total Workload(Hour) | 476 | |||||
Dersin AKTS Kredisi = Toplam İş Yükü (Saat)/30*=(476/30) | 16 | |||||
ECTS of the course: 30 hours of work is counted as 1 ECTS credit. |
Detail Informations of the Course
Course Description
Course | Code | Semester | T+P (Hour) | Credit | ECTS |
---|---|---|---|---|---|
CLINICS II | - | Spring Semester | 6+0 | 6 | 16 |
Course Program |
Prerequisites Courses | |
Recommended Elective Courses |
Language of Course | Turkish |
Course Level | Second Cycle (Master's Degree) |
Course Type | Elective |
Course Coordinator | Assist.Prof. Büşra Nur ÇATTIK |
Name of Lecturer(s) | Assist.Prof. Neda TANER, Assist.Prof. Rashıda Muhammad UMAR, Assist.Prof. Büşra Nur ÇATTIK |
Assistant(s) | |
Aim | It aims to target teaching advanced level information about cardiovascular system, central nervous system, kidney diseases, skin and soft tissue disorders, pregnancy, lactation and contraception, pain management and local and general anesthetic drugs. |
Course Content | This course contains; Osteoporosis and osteoarthritis and drug used in its treatment ,Acute coronary syndrome and drugs used in its treatment,Dyslipidemia and drugs used in its treatment,Eczema and psoriasis and drugs used in their treatment,Drugs that can be used in Pregnancy and lactation,Contraception methods,Acute kidney failure and drugs used in its treatment,Chronic kidney failure and drugs used in its treatment,Parkinson’s disease and drugs used in its treatment,Epilepsy and drugs used in its treatment,Alzheimer’s disease and drugs used in its treatment,Antidepressant and antimanic drugs,General and local anesthetics,Pain managements. |
Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
1. Analyzes the ability to understand and evaluate drugs used in the treatment of osteoporosis and osteoarthritis. | 11, 12, 2, 3, 4 | A, D, E |
2. Analyzes the ability to understand and evaluate drugs used in the treatment of acute coronary syndrome. | 11, 12, 2, 3, 4 | A, D, E |
3. Analyzes and discusses dyslipidemia and the drugs used in its treatment. | 11, 12, 2, 3, 4 | A, D, E |
4. Analyzes and discusses the drugs used in the treatment of eczema and psoriasis. | 11, 12, 2, 3, 4 | A, D, E |
5. Analyzes and discusses the drugs that can be used during pregnancy and lactation. | 11, 12, 2, 3, 4 | A, D, E |
6. Analyzes and discusses contraception methods. | 11, 12, 2, 3, 4 | A, D, E |
7. Analyzes and discusses acute renal failure and the drugs used in its treatment. | 11, 12, 2, 3, 4 | A, D, E |
8. Analyzes and discusses chronic renal failure and its treatment. | 11, 12, 2, 3, 4 | A, D, E |
9. Analyzes and discusses Parkinson's disease and its treatment. | 11, 12, 2, 3, 4 | A, D, E |
11. Analyzes and discusses the drugs used in the treatment of Alzheimer's. | 11, 12, 2, 3, 4 | A, D, E |
12. Analyzes and discusses antidepressants and antimanics. | 11, 12, 2, 3, 4 | A, D, E |
13. Analyzes and discusses general and local anesthetics. | 11, 12 | A, D, E |
14. Analyzes and discusses pain management. | 11, 12, 2, 3, 4 | A, D, E |
15. Decides on the treatment plan regarding these issues. | 11, 12, 2, 3, 4 | A, D, E |
Teaching Methods: | 11: Demonstration Method, 12: Problem Solving Method, 2: Project Based Learning Model, 3: Problem Baded Learning Model, 4: Inquiry-Based Learning |
Assessment Methods: | A: Traditional Written Exam, D: Oral Exam, E: Homework |
Course Outline
Order | Subjects | Preliminary Work |
---|---|---|
1 | Osteoporosis and osteoarthritis and drug used in its treatment | 1, 2 |
2 | Acute coronary syndrome and drugs used in its treatment | 1, 2 |
3 | Dyslipidemia and drugs used in its treatment | 1, 2 |
4 | Eczema and psoriasis and drugs used in their treatment | 1, 2 |
5 | Drugs that can be used in Pregnancy and lactation | 1, 2 |
6 | Contraception methods | 1, 2 |
7 | Acute kidney failure and drugs used in its treatment | 1, 2 |
8 | Chronic kidney failure and drugs used in its treatment | 1, 2 |
9 | Parkinson’s disease and drugs used in its treatment | 1, 2 |
10 | Epilepsy and drugs used in its treatment | 1, 2 |
11 | Alzheimer’s disease and drugs used in its treatment | 1, 2 |
12 | Antidepressant and antimanic drugs | 1, 2 |
13 | General and local anesthetics | 1, 2 |
14 | Pain managements | 1, 2 |
Resources |
Books: 1. Wells BG (2015) Pharmacotherapy handbook (9th ed), McGraw-Hill 2. Katzung BG (2012) Basic and clinical Pharmacology (12th ed) McGraw-Hill |
Course Contribution to Program Qualifications
Course Contribution to Program Qualifications | |||||||
No | Program Qualification | Contribution Level | |||||
1 | 2 | 3 | 4 | 5 | |||
1 | PY-1. Knows about accessing the scientific information in the field of clinical pharmacy, monitoring, evaluating, and implementing the current literature | X | |||||
2 | PY-2. Has the advanced knowledge of creating patient profiles, patient education, and medication counseling. | X | |||||
3 | PY-3. Cooperates with persons in relevant disciplines at the stages of collecting, interpreting, implementing, and announcing results of data related to the clinical pharmacy field | X | |||||
4 | PY-4. Uses the knowledge and equipment related to administering medicine to patients and the use of the drug. Gives pharmaceutical care service by providing rational and safe drug use with the duty of observance and supervision. | X | |||||
5 | PY-5. Acquires administrative and technical stand-by equipment in the areas where the clinical pharmacy is responsible for and achieves hospital pharmacy practices properly. | X | |||||
6 | PY-6. Produces solutions to the problems in the field of clinical pharmacy in the direction of scientific data/ scientific evidence. | X | |||||
7 | PY-7. Plans, manages, watches the process, and evaluates activities that oriented improvements of employees as part of a project. | X | |||||
8 | PY-8. Carries out a study independently by using advanced level knowledge about the field of clinical pharmacy and takes responsibility as a team member in cooperation with other occupational groups working in this field. | X | |||||
9 | PY-9. Demonstrates embarking on lifelong learning, open for improvement, and continue this behavior. | X | |||||
10 | PY-10. Follows and evaluates national and international developments in the field of clinical pharmacy. | X | |||||
11 | PY-11. Safely documents and keeps track of professional activities and practices. | X | |||||
12 | PY-12. Provides information to the patience, healthcare personnel, and society on every drug-related issue. | X | |||||
13 | PY-13. Informs relevant persons and institutions in the fields of quality assurance of pharmaceutical products | X | |||||
14 | PY-14. Behaves according to the legislation and professional ethics related to duty, right, and responsibilities as an individual. | X | |||||
15 | PY-15. Has sufficient consciousness in the field of individual and public health, environmental protection, and job security and applies it. | X |
Assessment Methods
Contribution Level | Absolute Evaluation | |
Rate of Midterm Exam to Success | 50 | |
Rate of Final Exam to Success | 50 | |
Total | 100 |